[Skip navigation] FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

Rulemaking History for OTC Menstrual Drug Products
View by Topic

Pending Final Monograph (21 CFR part 357 subpart K):  
Miscellaneous Internal Drug Products for Over-the-Counter Human Use


Date Federal Register Citation Description
12/7/1982 47FR55075 PDF document Advance Notice of Proposed Rulemaking
1/14/1983 48FR1758 PDF document Correction: Advance Notice of Proposed Rulemaking
2/18/1983 48FR7202 PDF document Correction: Advance Notice of Proposed Rulemaking
11/16/1988 53FR46194 PDF document Tentative Final Monograph
1/18/1989 54FR2039 PDF document Correction: Tentative Final Monograph
8/25/1992 57FR38568 PDF document Proposed Rule: Classifies category II and III ingredients without data as nonmonograph
9/8/1992 57FR40944 PDF document Correction: 8/25/1992 Proposed Rule
10/1/1992 57FR45295 PDF document Technical Amendment: Corrects an ingredient name (8/25/1992 Proposed Rule)
11/9/1992 57FR53300 PDF document Correction: 8/25/1992 Proposed Rule
5/10/1993 58FR27636 PDF document Final Rule: Classifies category II and III ingredients without data as nonmonograph

PDF document PDF requires the free Adobe Acrobat Reader

top arrow Back to Top     back arrow Back to Rulemaking Index

Date updated: April 26, 2007

horizonal rule